Friedman D, Mooppan U M, Rosen Y, Kim H
Department of Urology Brookdale Hospital Medical Center, Brooklyn, New York 11212.
J Urol. 1991 May;145(5):1060-3. doi: 10.1016/s0022-5347(17)38535-x.
The effects of intravesical instillations of thiotepa, mitomycin C and adriamycin on the normal urothelium were studied in rats. Changes in the bladder wall in the form of fibroblastic atypia and submucous fibrous plaques were significant in the mitomycin C treated group. In 46% of mitomycin C treated animals there was urothelial atypia and in one animal, the atypia was severe enough to resemble carcinoma in situ. None of the rats treated with thiotepa showed intramural fibrous plaques or fibroblastic atypia and only 8% showed urothelial atypia. In the group treated by adriamycin instillation, 17% showed intramural fibrous plaques, but none showed urothelial atypia or fibroblastic atypia. The fibroblastic atypia and submucosal fibrous plaques seen in the mitomycin treated group may explain the reduced bladder capacity seen in the clinical setting.
研究了噻替派、丝裂霉素C和阿霉素膀胱内灌注对大鼠正常尿路上皮的影响。丝裂霉素C治疗组膀胱壁出现成纤维细胞异型性和黏膜下纤维斑块形式的变化显著。在46%接受丝裂霉素C治疗的动物中存在尿路上皮异型性,且有一只动物的异型性严重到足以类似于原位癌。接受噻替派治疗的大鼠均未出现壁内纤维斑块或成纤维细胞异型性,仅有8%出现尿路上皮异型性。在阿霉素灌注治疗组中,17%出现壁内纤维斑块,但均未出现尿路上皮异型性或成纤维细胞异型性。丝裂霉素治疗组中所见的成纤维细胞异型性和黏膜下纤维斑块可能解释了临床所见膀胱容量减少的原因。